Sabon bugu na Rarraba Nama Mai Taushi da Ciwo Mai Kashi na Hukumar Lafiya ta Duniya, wanda aka buga a watan Afrilun 2020, ya rarrabasarcomascikin rukuni uku: ssau da yawa ciwon nama, ciwon ƙashi, da ciwon ƙashi da nama mai laushi tare da ƙananan ƙwayoyin halitta masu zagaye marasa bambanci(kamar EWSR1-non-ETS fusion round cell sarcoma).
"Ciwon Daji da Aka Manta"
Sarcoma wani nau'i ne mai saurin kamuwa da cutaciwon daji a cikin manya, lissafin game da1%na dukkan cututtukan daji na manya, waɗanda aka fi sani da "Ciwon Daji da Aka Manta." Duk da haka, yana da ɗan bambanci.abu ne da ya zama ruwan dare a cikin yara, lissafin kewaye15% zuwa 20%na dukkan cututtukan daji na yara. Yana iya faruwa a kowace sashe na jiki, galibi a cikinhannaye ko ƙafafu(kashi 60%), sai kumaakwati ko ciki(Kashi 30%), kuma a ƙarshekai ko wuya(10%).
A cikin 'yan shekarun nan, yawan kamuwa da ciwon ƙashi da nama mai laushi yana ƙaruwa a hankali. Ciwon ƙashi mai tsanani ya fi yawa a cikin matasa da kuma mutanen da ke da matsakaicin shekaru kuma sun haɗa da osteosarcoma, Ewing sarcoma, chondrosarcoma, malignant fibrous histiocytoma, da chordoma, da sauransu. Ciwon ƙashi mai laushi da aka saba gani ya haɗa da synovial sarcoma, fibrosarcoma, liposarcoma, da rhabdomyosarcoma. Ciwon ƙashi ya fi yawa a cikin mutanen da ke da matsakaicin shekaru da tsofaffi, tare da ciwon ƙashi na farko da aka saba gani sune ciwon huhu, ciwon nono, ciwon koda, ciwon prostate, da ciwon thyroid, da sauransu.
Ganowa Da Wuri, Maganin Da Wuri Da Wuri - Haskaka "Ƙwayoyin Ciki" da Aka Boye
Saboda yawan sake dawowar sarcomas gaba ɗaya, yawancin ciwace-ciwacen suna da alamun cutar kafin tiyata ba tare da cikakken bayani ba kuma ba su da cikakkun gwaje-gwajen hoto. Wannan yakan haifar da gano cewa ciwon ba shi da sauƙi kamar yadda aka kiyasta kafin tiyata, wanda ke haifar da cirewa ba tare da cikakke ba. Komawa ko kuma ya faru bayan tiyata na iya faruwa, wanda ke sa marasa lafiya su rasa damar magani mafi kyau. Saboda haka,Ganowa da wuri, gano ainihin cutar, da kuma magani a kan lokaci yana da matuƙar muhimmanci ga hasashen lafiyar marasa lafiya. A yau, muna son gabatar da wani kwararre mai daraja wanda ke da kusan shekaru 20 na gwaninta a aikina cikin ganewar asali da kuma maganin musamman na sarcoma na nama mai laushi, kuma masana'antar da marasa lafiya suna yaba masa sosai -LikitaLiu Jiayongdaga Sashen Kashi da Taushi na Nama a Asibitin Ciwon Daji na Jami'ar Peking.
Bayyanar da Kwararren Mai Zurfin Ilimi Game da Ciwon Kashi da Nama – Dr..Liu Jiayong
Likitan Magani, Babban Likita, Mataimakin Farfesa. Ya yi karatu a Cibiyar Ciwon Daji ta Anderson da ke Amurka.
Gwaninta:Cikakken magani na sarcomas na nama mai laushi (fiɗa da sake ginawa ta tiyata; chemotherapy, maganin da aka yi niyya, da kuma maganin rigakafi); maganin tiyata na melanoma.
Tare da kusan shekaru 20 na ƙwarewar likitanci, Likita Liu Jiayong ya tara ƙwarewa mai zurfi a fannin magani da tiyata a fannin likitanci.ganewar asali da tsare-tsaren magani na musammanga sarcoma na nama mai laushi kamar su sarcoma pleomorphic mara bambanci, liposarcoma, leiomyosarcoma, sarcoma synovial, adenocystic carcinoma-like sarcoma, epithelioid sarcoma, fibrosarcoma, angiosarcoma, da fibromatosis infiltrative. Yana da matuƙar haɗari musamman.Kwarewa wajen sarrafa jijiyoyin jini da jijiyoyi yayin yankewar sarcoma a gaɓoɓi, da kuma gyara da sake gina lahani na nama mai laushi a fata.Likita Liu yana sauraron kowanne majiyyaci cikin haƙuri, yana bincika tarihin lafiyarsa sosai, sannan yana ɗaukar bayanan lafiya masu kyau. Yana mai da hankali sosai ga canje-canjen da ke faruwa a yanayin majiyyacin a lokutan daban-daban, kamar kafin da bayan tiyata, yayin magani, bin diddigin cutar, da kuma ci gabanta, yana yin hukunci mai kyau da kuma daidaita tsare-tsaren magani a kan lokaci.
A halin yanzu Likita Liu Jiayong yana aiki a matsayin memba na ƙungiyar Soft Tissue Sarcoma da Melanoma Group na ƙungiyar hana ciwon daji ta ƙasar Sin, haka kuma memba ne na ƙungiyar Bone Tumor na ƙungiyar kashin baya ta Beijing Society of Orthopedics na ƙungiyar likitocin ƙasar Sin.A shekarar 2010, shi ne na farko a kasar Sin da ya fassara tare da buga "Jagororin Aikin Likitanci na NCCN a Kan Sanƙarar Nama Mai Taushi," wanda ke haɓaka cikakken magani na sarcoma na nama mai laushi.Yana ci gaba da ƙoƙarin samun ci gaba a binciken asibiti da kimiyya, duk da cewa yana da nauyi mai yawa ga marasa lafiya. Yana da himma da kuma alhakin kowane majiyyaci da yake yi wa magani, kuma a lokacin annobar, ya magance matsalolin da marasa lafiya ke fuskanta wajen neman kulawar likita ta hanyar amsa tambayoyin marasa lafiya cikin gaggawa, sake duba sakamakon da aka samu, da kuma bayar da shawarwarin magani masu dacewa ta hanyar dandamalin shawarwari ta yanar gizo kamar Good Doctor's Patient Group.
Shari'ar Kwanan Nan
Mista Zhang, majiyyaci mai shekaru 35, ya samu matsalar gani kwatsam a farkon shekarar 2019. Daga baya, an yi masa tiyatar cire ido daga ido saboda ci gaba da ƙaruwar matsin lamba a ido. Sakamakon cutar bayan tiyata ya nuna wani kumburin fata mai kama da kumburi. A lokacin bazara na wannan shekarar, an gano ƙwayoyin huhu da yawa a lokacin gwajin ci gaba, amma ba a gano ƙwayoyin ƙari ba ta hanyar amfani da allurar biopsy. Ci gaba da gwaje-gwajen da aka yi sun nuna cewa akwai ƙwayoyin ƙashi da huhu da yawa. Tuntuɓa a asibitoci na gida da na sama sun gano shi da ciwon kumburi na myofibroblastic. A watan Agusta na 2022, an yi masa maganin chemotherapy mai yawa, wanda ya rage masa radadi sosai amma bai nuna wani ci gaba a raunukan ba bayan sake kimantawa. Yanayin jikinsa ma ya raunana. Duk da haka, iyalinsa ba su taɓa yanke ƙauna ba. Bayan neman ra'ayoyi da yawa, sun zo wurin Likita Liu Jiayong a watan Nuwamba na 2022. Bayan sun yi nazari sosai kan tarihin lafiyar majiyyacin, duk bayanan likita, gwaje-gwajen cututtuka, da bayanan hoto,LikitaLiu ya gabatar da tsarin maganin chemotherapy wanda ya ƙunshi ƙananan allurai na methotrexate da Changchun Ruibin.Wannan tsarin maganin chemotherapy yana da inganci kuma yana da ƙarancin illa. Bayan kwanaki 35 na magani, gwajin CT na gaba ya nuna cewa tarin da ke cikin huhun dama ya ɓace, wanda ke nuna kyakkyawan iko akan ciwon.Wani bincike da aka yi kwanan nan a Asibitin Kula da Cututtukan Jiki na Yankin Kudu na Beijing ya nuna yanayin huhu mai kyau, kuma Doctor Liu ya ba da shawarar a riƙa ziyartar marasa lafiya akai-akai. Majinyacin da iyalinsa yanzu suna da ƙarin kwarin gwiwa game da maganin da zai biyo baya, cike da bege. Suna jin cewa sun ga ɗan haske a tafiyar magani kuma suna nuna godiyarsu ta zuciya ta hanyar gabatar da alamar godiya.
Lokacin Saƙo: Agusta-25-2023